本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cogent Biosciences, Inc.

36.80
+0.57001.57%
盤後37.000.2000+0.54%17:24 EDT
成交量:139.43萬
成交額:5,124.91萬
市值:63.86億
市盈率:-17.04
高:37.08
開:36.56
低:36.44
收:36.23
52周最高:43.73
52周最低:11.60
股本:1.74億
流通股本:1.67億
量比:0.86
換手率:0.84%
股息:- -
股息率:- -
每股收益(TTM):-2.1600
每股收益(LYR):-2.5504
淨資產收益率:-109.74%
總資產收益率:-43.84%
市淨率:13.66
市盈率(LYR):-14.43

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/10

重要事件披露

Form 8-K - Current report
2026/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/10

重要事件披露

Form 8-K - Current report
2026/07/31

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/28

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/12

重要事件披露

Form 8-K - Current report
2026/05/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/03/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/17

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/17

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/17

重要事件披露

Form 8-K - Current report
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/08

重要事件披露

Form 8-K - Current report